Tuthill MH - Search Results

1

TRAIL-R2-specific antibodies and recombinant TRAIL can synergise to kill cancer cells.

Tuthill MH, Montinaro A, Zinngrebe J, Prieske K, Draber P, Prieske S, Newsom-Davis T, von Karstedt S, Graves J, Walczak H. Tuthill MH, et al. Oncogene. 2015 Apr 16;34(16):2138-2144. doi: 10.1038/onc.2014.156. Epub 2014 Jun 9. Oncogene. 2015. PMID: 24909167 Free PMC article.

2

Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma.

Bower M, Stebbing J, Tuthill M, Campbell V, Krell J, Holmes P, Ozzard A, Nelson M, Gazzard B, Powles T. Bower M, et al. Blood. 2008 Apr 15;111(8):3986-90. doi: 10.1182/blood-2007-10-115659. Epub 2008 Jan 2. Blood. 2008. PMID: 18172004 Free article.

3

New drugs for prostate cancer.

Alifrangis C, O'Hanlon-Brown C, Tuthill M, Waxman J. Alifrangis C, et al. BJU Int. 2012 Jun;109(12):1801-6. doi: 10.1111/j.1464-410X.2011.10570.x. Epub 2011 Sep 20. BJU Int. 2012. PMID: 21933331 Review.

4

Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis.

Tuthill M, Pell R, Guiliani R, Lim A, Gudi M, Contractor KB, Lewis JS, Coombes RC, Stebbing J. Tuthill M, et al. Eur J Cancer. 2009 Aug;45(12):2146-9. doi: 10.1016/j.ejca.2009.04.027. Epub 2009 May 20. Eur J Cancer. 2009. PMID: 19464163

5

Urothelial cancer: a narrative review of the role of novel immunotherapeutic agents with particular reference to the management of non-muscle-invasive disease.

Doyle E, Crew J, Mostafid H, Tuthill M, Cerundolo V, Gerristen W, Protheroe A. Doyle E, et al. BJU Int. 2019 Jun;123(6):947-958. doi: 10.1111/bju.14643. Epub 2019 Jan 22. BJU Int. 2019. PMID: 30548196 Review.

6

HIV-associated renal cell cancer.

Hulbert F, Ozzard A, Tuthill M, Bower M. Hulbert F, et al. J HIV Ther. 2007 Sep;12(3):73-4. J HIV Ther. 2007. PMID: 17962798 No abstract available.

7

Large bowel perforation associated with capecitabine treatment for breast cancer.

Cowman S, Stebbing J, Tuthill M. Cowman S, et al. Ann Oncol. 2008 Aug;19(8):1510-1511. doi: 10.1093/annonc/mdn397. Epub 2008 Jun 18. Ann Oncol. 2008. PMID: 18562326 Free article. No abstract available.

8

The cost of a QALY.

Kirkdale R, Krell J, Brown CO, Tuthill M, Waxman J. Kirkdale R, et al. QJM. 2010 Sep;103(9):715-20. doi: 10.1093/qjmed/hcq081. Epub 2010 Jun 2. QJM. 2010. PMID: 20519275

9

DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma.

Lee S, Syed N, Taylor J, Smith P, Griffin B, Baens M, Bai M, Bourantas K, Stebbing J, Naresh K, Nelson M, Tuthill M, Bower M, Hatzimichael E, Crook T. Lee S, et al. Br J Cancer. 2010 Jul 13;103(2):265-74. doi: 10.1038/sj.bjc.6605711. Epub 2010 Jun 15. Br J Cancer. 2010. PMID: 20551953 Free PMC article.

10

No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.

De La Pena H, Sharma A, Glicksman C, Joseph J, Subesinghe M, Traill Z, Verrill C, Sullivan M, Redgwell J, Bataillard E, Pintus E, Dallas N, Gogbashian A, Tuthill M, Protheroe A, Hall M. De La Pena H, et al. Eur J Cancer. 2017 Oct;84:354-359. doi: 10.1016/j.ejca.2017.07.005. Epub 2017 Sep 1. Eur J Cancer. 2017. PMID: 28866371 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page